loader image

GLOW

SKU GLOW Category

GLOW is a laboratory-formulated research peptide blend supplied by AusPepLabs, combining three extensively studied research compounds — TB-500 (Thymosin Beta-4), BPC-157, and GHK-Cu (Copper Tripeptide-1) – in a single 70mg lyophilized vial. Each component targets distinct molecular pathways, making GLOW a useful multi-pathway research tool for laboratories investigating cytoskeletal biology, gastrointestinal peptide signaling, and copper-dependent cellular modeling within a single experimental system. Each vial is independently verified to ≥99% HPLC purity with a Certificate of Analysis available on request. For scientific research use only.

Why Research Laboratories Select GLOW

GLOW combines three mechanistically distinct research peptides in a single convenient vial, enabling laboratories to investigate multiple signaling pathways simultaneously. TB-500 acts on cytoskeletal actin dynamics via the LKKTETQ active site. BPC-157 interacts with nitric oxide and VEGF signaling pathways. GHK-Cu modulates copper-dependent enzymatic activity and extracellular matrix signaling. Together they provide a multi-pathway reference system relevant to tissue biology and cellular remodeling research.

  • Three-component blend – TB-500, BPC-157, and GHK-Cu in one 70mg lyophilized vial
  • Multi-pathway research system – cytoskeletal, gastrointestinal peptide, and copper-dependent signaling studied simultaneously
  • GHK-Cu at 50mg dominant concentration – suited for extracellular matrix and copper-peptide complex research
  • TB-500 and BPC-157 at 10mg each -complementary tissue biology research concentrations
  • Each component independently verified to ≥99% HPLC purity
  • Lyophilized format ensures stability and reproducibility across experimental runs
Component Overview
TB-500 (10mg) (CAS 77591-33-4.) 43 amino acid synthetic peptide corresponding to Thymosin Beta-4. Studied for actin-binding properties, G-actin sequestration, and cytoskeletal remodeling in preclinical research models.
BPC-157 (10mg) (CAS 137525-51-0.) 15 amino acid synthetic pentadecapeptide derived from human gastric juice protein. Studied for nitric oxide pathway interactions and angiogenic signaling in preclinical research models.
GHK-Cu (50mg) (CAS 49557-75-7). Naturally occurring copper-binding tripeptide (Gly-His-Lys·Cu²⁺). Studied for extracellular matrix signaling, copper-dependent enzymatic activity, and gene expression modulation in cellular research models.

This product is currently out of stock and unavailable.

⚠️ Important Notice:
This product is sold strictly for laboratory research purposes only. It is not for human or animal use, and not for therapeutic or diagnostic applications.
 
By purchasing, you confirm that you are a qualified individual using this product in accordance with all applicable laws and research regulations.

Description

GLOW is a laboratory-formulated research peptide blend supplied by AusPepLabs, combining three extensively studied research compounds — TB-500 (Thymosin Beta-4), BPC-157, and GHK-Cu (Copper Tripeptide-1) – in a single 70mg lyophilized vial. Each component targets distinct molecular pathways, making GLOW a useful multi-pathway research tool for laboratories investigating cytoskeletal biology, gastrointestinal peptide signaling, and copper-dependent cellular modeling within a single experimental system. Each vial is independently verified to ≥99% HPLC purity with a Certificate of Analysis available on request. For scientific research use only.

Why Research Laboratories Select GLOW

GLOW combines three mechanistically distinct research peptides in a single convenient vial, enabling laboratories to investigate multiple signaling pathways simultaneously. TB-500 acts on cytoskeletal actin dynamics via the LKKTETQ active site. BPC-157 interacts with nitric oxide and VEGF signaling pathways. GHK-Cu modulates copper-dependent enzymatic activity and extracellular matrix signaling. Together they provide a multi-pathway reference system relevant to tissue biology and cellular remodeling research.

  • Three-component blend – TB-500, BPC-157, and GHK-Cu in one 70mg lyophilized vial
  • Multi-pathway research system – cytoskeletal, gastrointestinal peptide, and copper-dependent signaling studied simultaneously
  • GHK-Cu at 50mg dominant concentration – suited for extracellular matrix and copper-peptide complex research
  • TB-500 and BPC-157 at 10mg each -complementary tissue biology research concentrations
  • Each component independently verified to ≥99% HPLC purity
  • Lyophilized format ensures stability and reproducibility across experimental runs
Component Overview
TB-500 (10mg) (CAS 77591-33-4.) 43 amino acid synthetic peptide corresponding to Thymosin Beta-4. Studied for actin-binding properties, G-actin sequestration, and cytoskeletal remodeling in preclinical research models.
BPC-157 (10mg) (CAS 137525-51-0.) 15 amino acid synthetic pentadecapeptide derived from human gastric juice protein. Studied for nitric oxide pathway interactions and angiogenic signaling in preclinical research models.
GHK-Cu (50mg) (CAS 49557-75-7). Naturally occurring copper-binding tripeptide (Gly-His-Lys·Cu²⁺). Studied for extracellular matrix signaling, copper-dependent enzymatic activity, and gene expression modulation in cellular research models.

Additional information

Dosage

70mg

Reviews

There are no reviews yet.

Be the first to review “GLOW”

Your email address will not be published. Required fields are marked *

Returns and Refunds

We accept bank transfer payments. After placing your order, you will see our bank details (PAYID, BSB, and Account Number). Please use your order number as the payment reference.

Express shipping takes 2-4 business days. Standard shipping takes 5-8 business days. Free express shipping on orders over $250.

Yes, all our AUSPEPLABS
are HPLC tested for purity (99%+). Certificates of Analysis are available upon request

Unlock 25% OFF
Your First Order!

Subscribe for updates, offers & peptide wellness tips.